RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..6 of 6 - per page
Order by
Rx and /or OTC dermatology products
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
UK Marketing Partner
Are you a small to medium company seeking a UK presence? More
Acquisition of UK Hospital established brands
UK partner for strategic divestments More
Acquisition of UK Primary Care ethical brands
Strategic divestments of primary care sales focussed brands More
Injectables and oral medicines for hospital use
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets More
Displaying 1..6 of 6 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Infectious Diseases Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Infectious Disease Research Institute – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 28 pages - $500
Deals and alliances in infectious diseases
Jun 2006 - 1458 pages - $2,495
Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management
Oct 2009 - 17 pages - $500
Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)
Oct 2011 - 150 pages - $3,500
Lyme Disease Global Clinical Trials Review, Q1, 2011
Feb 2011 - 26 pages - $1,000
Cutaneous Mastocytosis Global Clinical Trials Review, Q1, 2011
Mar 2011 - 20 pages - $1,000
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 32 pages - $250
Leishmaniasis (Kala-Azar) Global Clinical Trials Review, Q1, 2011
Jan 2011 - 42 pages - $1,000
More Related Market Research Reports >>>

Your selection

Therapeutic target
Infectious diseases del
Development phase
Phase I/II del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools
Therapeutic target
Bacteria or virus
Bioterrorism
Diseases
Hepatitis (other)
Nosocomial infections
Parasitic diseases
Treatments

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us